Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Involvement of vulva in lichen sclerosus increases the risk of antidepressant and benzodiazepine prescriptions for psychiatric disorder diagnoses

Abstract

While vulvar lichen sclerosus (VLS) causes intense pruritus, associated risks of mood disorders and prescription patterns and impact of concurrent sexual dysfunction are unknown. We queried TriNetX Diamond Network between 2009 and 2022, conducting three comparisons after propensity-score matching for demographics and relevant comorbidities: (1) women with lichen sclerosus (LS) sparing the vulva vs. women with VLS; (2) VLS patients who received treatment within 6 months of diagnosis vs. patients who did not and (3) VLS patients with vs. without sexual dysfunction. Outcomes included new depressive episodes, anxiety disorder, major depressive disorder (MDD), and prescriptions of antidepressants or benzodiazepines. After matching, VLS was associated with increased depressive episode [risk ratio (RR) 1.39], anxiety disorder (RR 1.93), and MDD (RR 2.00) diagnoses compared to LS sparing the vulva. Next, VLS treatment was associated with decreased risk of depressive episode (RR 0.60) and anxiety disorder (RR 0.72). Finally, concurrent sexual dysfunction was associated with increased benzodiazepine (RR 3.50), vaginal estrogen (RR 6.20), antipruritic agents (RR 3.90), and topical anti-inflammatory (RR 2.61) prescriptions. In conclusion, vulvar involvement is associated with increased risk of antidepressant and benzodiazepine prescriptions, and diagnosis of depressive episode, anxiety disorder, or MDD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flow chart of cohort construction.

Similar content being viewed by others

Data availability

The data used in this study are from the TriNetX deidentified database, which is available from TriNetX, LLC (https://trinetx.com/). Third-party restrictions affect availability of these data that prevent it from being made publicly available or redistributed. Researchers can access the TriNetX database through TriNetX, LLC.

References

  1. Kraus CN. Vulvar Lichen Sclerosus. JAMA Dermatol. 2022;158:1088. https://doi.org/10.1001/jamadermatol.2022.0359.

    Article  PubMed  Google Scholar 

  2. Van de Nieuwenhof HP, Meeuwis KAP, Nieboer TE, Vergeer MCM, Massuger LFAG, De Hullu JA. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol. 2010;31:279–84. https://doi.org/10.3109/0167482X.2010.507890.

    Article  PubMed  Google Scholar 

  3. Rivera S, Flood A, Dykstra C, Herbenick D, DeMaria AL. Genital Self-Image, Sexual Function, and Quality of Life Among Individuals with Vulvar and Non-Vulvar Inflammatory Dermatoses. Arch Sex Behav. Published online July 28, (2022). https://doi.org/10.1007/s10508-022-02353-0.

  4. Sadownik LA, Koert E, Maher C, Smith KB. A Qualitative Exploration of Women’s Experiences of Living With Chronic Vulvar Dermatoses. J Sex Med. 2020;17:1740–50. https://doi.org/10.1016/j.jsxm.2020.06.016.

    Article  PubMed  Google Scholar 

  5. Brauer M, van Lunsen R, Burger M, Laan E. Motives for Vulvar Surgery of Women with Lichen Sclerosus. J Sex Med. 2015;12:2462–73. https://doi.org/10.1111/jsm.13052.

    Article  PubMed  Google Scholar 

  6. Chmel R, Nováčková M, Fait T, Zámečník L, Krejčová L, Pastor Z. Clitoral Phimosis: Effects on Female Sexual Function and Surgical Treatment Outcomes. J Sex Med. 2019;16:257–66. https://doi.org/10.1016/j.jsxm.2018.12.012.

    Article  PubMed  Google Scholar 

  7. Haefner HK, Aldrich NZ, Dalton VK, Gagné HM, Marcus SB, Patel DA, et al. The impact of vulvar lichen sclerosus on sexual dysfunction. J Womens Health 2002. 2014;23:765–70. https://doi.org/10.1089/jwh.2014.4805.

    Article  Google Scholar 

  8. Corazza M, Borghi A, Gafà R, Ghirardi C, Ferretti S. Risk of vulvar carcinoma in women affected with lichen sclerosus: results of a cohort study. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2019;17:1069–71. https://doi.org/10.1111/ddg.13961.

    Article  Google Scholar 

  9. Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151:1061–7. https://doi.org/10.1001/jamadermatol.2015.0643.

    Article  PubMed  Google Scholar 

  10. Corazza M, Borghi A, Minghetti S, Toni G, Virgili A. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial. J Eur Acad Dermatol Venereol JEADV. 2016;30:956–61. https://doi.org/10.1111/jdv.13166.

    Article  CAS  PubMed  Google Scholar 

  11. Virgili A, Minghetti S, Borghi A, Corazza M. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. Br J Dermatol. 2013;168:1316–24. https://doi.org/10.1111/bjd.12273.

    Article  CAS  PubMed  Google Scholar 

  12. Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am J Clin Dermatol. 2018;19:695–706. https://doi.org/10.1007/s40257-018-0364-7.

    Article  PubMed  Google Scholar 

  13. Day T, Otton G, Dennerstein G, Tran H, Scurry J. Erosive Lichen sclerosus—a clinicopathologic subtype. J Low Genit Tract Dis. 2021;25:255–60. https://doi.org/10.1097/LGT.0000000000000607.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mazdisnian F, Degregorio F, Mazdisnian F, Palmieri A. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med. 1999;44:332–4.

    CAS  PubMed  Google Scholar 

  15. Lutfey KE, Link CL, Rosen RC, Wiegel M, McKinlay JB. Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) Survey. Arch Sex Behav. 2009;38:514–27. https://doi.org/10.1007/s10508-007-9290-0.

    Article  PubMed  Google Scholar 

  16. Cheng H, Oakley A, Conaglen JV, Conaglen HM. Quality of life and sexual distress in women with erosive vulvovaginal lichen planus. J Low Genit Tract Dis. 2017;21:145–9. https://doi.org/10.1097/LGT.0000000000000282.

    Article  PubMed  Google Scholar 

  17. Skrzypulec V, Olejek A, Drosdzol A, Nowosielski K, Kozak-Darmas I, Wloch S. Sexual functions and depressive symptoms after photodynamic therapy for vulvar lichen sclerosus in postmenopausal women from the Upper Silesian Region of Poland. J Sex Med. 2009;6:3395–400. https://doi.org/10.1111/j.1743-6109.2009.01505.x.

    Article  PubMed  Google Scholar 

  18. Burrows LJ, Creasey A, Goldstein AT. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Med. 2011;8:219–22. https://doi.org/10.1111/j.1743-6109.2010.02077.x.

    Article  PubMed  Google Scholar 

  19. ICD-10-CM. Accessed August 26, (2023). https://icd10cmtool.cdc.gov/.

  20. Rights (OCR) O for C. The HIPAA Privacy Rule. HHS.gov. Published May 7, 2008. Accessed October 8, (2023). https://www.hhs.gov/hipaa/for-professionals/privacy/index.html.

  21. Fan R, Leasure AC, Maisha FI, Little AJ, Cohen JM. Depression and anxiety in patients with lichen sclerosus. JAMA Dermatol. 2022;158:953–4. https://doi.org/10.1001/jamadermatol.2022.1964.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Govind V, Mitchell L, Tolson H, Barela K, Casey J, Goldstein A. 089 exploring comorbidity of anxiety and depression in lichen sclerosus. J Sex Med. 2019;16:S34. https://doi.org/10.1016/j.jsxm.2019.03.530.

    Article  Google Scholar 

  23. Timur S, Sahin NH. The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause N Y N. 2010;17:545–51. https://doi.org/10.1097/gme.0b013e3181cf8997.

    Article  Google Scholar 

  24. Jung SJ, Shin A, Kang D. Hormone-related factors and post-menopausal onset depression: results from KNHANES (2010-2012). J Affect Disord. 2015;175:176–83. https://doi.org/10.1016/j.jad.2014.12.061.

    Article  CAS  PubMed  Google Scholar 

  25. Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;(12):CD008240. https://doi.org/10.1002/14651858.CD008240.pub2.

  26. Hosseinzadeh Zoroufchi B, Doustmohammadi H, Mokhtari T, Abdollahpour A. Benzodiazepines related sexual dysfunctions: A critical review on pharmacology and mechanism of action. Rev Int Androl. 2021;19:62–68. https://doi.org/10.1016/j.androl.2019.08.003.

    Article  PubMed  Google Scholar 

  27. Margesson LJ. Practice gaps: Practice gaps “down there”: failures in education, physical examination, recognition, diagnosis, therapy, follow-up care, and cancer surveillance in lichen sclerosus. JAMA Dermatol. 2013;149:1203. https://doi.org/10.1001/jamadermatol.2013.4895.

    Article  PubMed  Google Scholar 

  28. Bleeker MCG, Visser PJ, Overbeek LIH, van Beurden M, Berkhof J. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2016;25:1224–30. https://doi.org/10.1158/1055-9965.EPI-16-0019.

    Article  CAS  Google Scholar 

  29. Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol. 2006;142:289–94. https://doi.org/10.1001/archderm.142.3.289.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

UEC and TK analyzed the data and UEC, RCN and EW wrote the article. PA, TK, JK, and MC provided substantial edits and guidance. All authors revised the article and approved the final manuscript.

Corresponding author

Correspondence to Taylor P. Kohn.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

This study was exempt from IRB approval as only anonymized data was used.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, U.E., Nicholson, R.C., Agrawal, P. et al. Involvement of vulva in lichen sclerosus increases the risk of antidepressant and benzodiazepine prescriptions for psychiatric disorder diagnoses. Int J Impot Res (2023). https://doi.org/10.1038/s41443-023-00793-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41443-023-00793-3

Search

Quick links